Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states
- PMID: 16999719
- PMCID: PMC1618805
- DOI: 10.1111/j.1365-2257.2006.00812.x
Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states
Abstract
Direct measurement of the reticulocyte hemoglobin content provides useful information for the diagnosis and treatment of iron-deficient states. We have examined direct measurements of reticulocyte and red cell hemoglobin content on the Sysmex XE 2100 (Ret He and RBC He respectively) and the Bayer ADVIA 2120 (CHr and CH respectively) analyzers. Good agreement was found between Ret He and CHr (Y = 1.04X - 1.06; r2= 0.88) and between the RBC He and CH parameters (Y = 0.93X + 1; r2= 0.84 n = 200) in pediatric patients and in normal adults (Ret He and CHr; Y = 1.06X - 0.43; r2= 0.83; n = 126; RBC He and CH; Y = 0.94X + 1; r2= 0.87; n = 126). In 1500 blood samples from patients on chronic dialysis, Ret He was compared with traditional parameters for iron deficiency (serum iron <40 microg/dl, Tsat <20%, ferritin <100 ng/ml, hemoglobin <11 g/dl) for identifying iron-deficient states. Receiver operator characteristic (ROC) curve analysis revealed values of the area under the curve for Ret He of 0.913 (P < 0.0001). With a Ret He cutoff level of 27.2 pg, iron deficiency could be diagnosed with a sensitivity of 93.3%, and a specificity of 83.2%. Ret He is a reliable marker of cellular hemoglobin content and can be used to identify the presence of iron-deficient states.
Figures




Similar articles
-
Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency.Int J Lab Hematol. 2010 Apr;32(2):248-55. doi: 10.1111/j.1751-553X.2009.01179.x. Epub 2009 Jul 13. Int J Lab Hematol. 2010. PMID: 19624802
-
Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.Pediatr Nephrol. 2016 May;31(5):819-26. doi: 10.1007/s00467-015-3284-2. Epub 2015 Dec 14. Pediatr Nephrol. 2016. PMID: 26667237
-
Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy.Lab Hematol. 2007;13(1):6-11. doi: 10.1532/LH96.06037. Lab Hematol. 2007. PMID: 17353176
-
The Role of Reticulocyte Hemoglobin Content for Diagnosis of Iron Deficiency and Iron Deficiency Anemia, and Monitoring of Iron Therapy: a Literature Review.Clin Lab. 2019 Dec 1;65(12). doi: 10.7754/Clin.Lab.2019.190315. Clin Lab. 2019. PMID: 31850722 Review.
-
Implementing Reticulocyte Hemoglobin Into Current Hematology Algorithms.Am J Clin Pathol. 2022 Nov 3;158(5):574-582. doi: 10.1093/ajcp/aqac103. Am J Clin Pathol. 2022. PMID: 36048898
Cited by
-
Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patients.Clin Kidney J. 2014 Jun;7(3):275-81. doi: 10.1093/ckj/sfu038. Epub 2014 May 14. Clin Kidney J. 2014. PMID: 25852889 Free PMC article.
-
Accuracy of reticulocyte hemoglobin for diagnosing iron deficiency in former very preterm infants: a population-based cohort study.Front Pediatr. 2023 Nov 20;11:1281513. doi: 10.3389/fped.2023.1281513. eCollection 2023. Front Pediatr. 2023. PMID: 38054186 Free PMC article.
-
Blood Biomarker Profiling and Monitoring for High-Performance Physiology and Nutrition: Current Perspectives, Limitations and Recommendations.Sports Med. 2019 Dec;49(Suppl 2):185-198. doi: 10.1007/s40279-019-01158-x. Sports Med. 2019. PMID: 31691931 Free PMC article. Review.
-
Improved Diagnosis of Iron Deficiency Anemia in the Critically Ill via Fluorescence Flowcytometric Hemoglobin Biomarkers.Cells. 2022 Dec 29;12(1):140. doi: 10.3390/cells12010140. Cells. 2022. PMID: 36611936 Free PMC article.
-
Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease.Nutrients. 2018 Jan 13;10(1):82. doi: 10.3390/nu10010082. Nutrients. 2018. PMID: 29342861 Free PMC article. Review.
References
-
- Brugnara C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Critical Reviews in Clinical Laboratory Sciences. 2000;37:93–130. - PubMed
-
- Brugnara C. Iron deficiency and erythropoiesis: New diagnostic approaches. Clinical Chemistry. 2003;49:1573–1578. - PubMed
-
- Brugnara C, Laufer MR, Friedman AI, Platt O. Reticulocyte hemoglobin content (Chr) – early indicator of response to iron therapy. Blood. 1993;82:A93. - PubMed
-
- Brugnara C, Colella GM, Cremins J, Langley RC, Schneider TJ, Rutherford CJ, Goldberg MA. Effects of subcutaneous recombinant-human-erythropoietin in normal subjects – development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. Journal of Laboratory and Clinical Medicine. 1994a;123:660–667. - PubMed
-
- Brugnara C, Colella GM, Cremins JC, Langley RC, Schneider TJ, Rutheford CJ, Goldberg MA. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. The Journal of Laboratory and Clinical Medicine. 1994b;123:660–667. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical